Jake Rosenberg, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polyendocrinopathies, Autoimmune | 2 | 2022 | 56 | 1.360 |
Why?
|
Mucormycosis | 1 | 2022 | 103 | 0.730 |
Why?
|
Autoantibodies | 4 | 2018 | 2116 | 0.720 |
Why?
|
Anemia, Aplastic | 1 | 2022 | 230 | 0.680 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2017 | 547 | 0.490 |
Why?
|
Traumatology | 1 | 2015 | 100 | 0.470 |
Why?
|
Memory, Long-Term | 1 | 2014 | 59 | 0.460 |
Why?
|
Interferon-alpha | 1 | 2018 | 921 | 0.440 |
Why?
|
Cryoglobulinemia | 1 | 2014 | 84 | 0.440 |
Why?
|
Attitude to Death | 1 | 2015 | 400 | 0.400 |
Why?
|
Professional-Family Relations | 1 | 2015 | 495 | 0.370 |
Why?
|
Fingers | 1 | 2014 | 507 | 0.370 |
Why?
|
Professional-Patient Relations | 1 | 2015 | 726 | 0.340 |
Why?
|
Portal Vein | 1 | 2012 | 431 | 0.340 |
Why?
|
Nicotine | 1 | 2014 | 680 | 0.340 |
Why?
|
Cocaine | 1 | 2014 | 958 | 0.330 |
Why?
|
Clinical Clerkship | 1 | 2015 | 564 | 0.320 |
Why?
|
Antibodies, Neutralizing | 2 | 2018 | 1943 | 0.320 |
Why?
|
Gastrectomy | 1 | 2012 | 672 | 0.290 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4544 | 0.270 |
Why?
|
Ischemia | 1 | 2014 | 1883 | 0.250 |
Why?
|
Cytokines | 2 | 2015 | 7396 | 0.220 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1303 | 0.210 |
Why?
|
Acetonitriles | 1 | 2022 | 54 | 0.200 |
Why?
|
Students, Medical | 1 | 2015 | 1936 | 0.200 |
Why?
|
Obesity, Morbid | 1 | 2012 | 1277 | 0.190 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2020 | 19 | 0.180 |
Why?
|
Laparoscopy | 1 | 2012 | 2036 | 0.180 |
Why?
|
STAT1 Transcription Factor | 1 | 2022 | 341 | 0.180 |
Why?
|
HIV-2 | 1 | 2020 | 156 | 0.170 |
Why?
|
Autoantigens | 2 | 2015 | 891 | 0.170 |
Why?
|
Latent Tuberculosis | 1 | 2021 | 224 | 0.150 |
Why?
|
Gait Disorders, Neurologic | 1 | 2020 | 240 | 0.150 |
Why?
|
Pulmonary Fibrosis | 1 | 2022 | 505 | 0.150 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4420 | 0.150 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2017 | 35 | 0.150 |
Why?
|
Smith-Magenis Syndrome | 1 | 2017 | 19 | 0.140 |
Why?
|
Toxoplasmosis | 1 | 2017 | 94 | 0.140 |
Why?
|
Fatal Outcome | 1 | 2022 | 1835 | 0.140 |
Why?
|
Pyrroles | 1 | 2022 | 1125 | 0.130 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2015 | 173 | 0.120 |
Why?
|
Sympathectomy | 1 | 2014 | 72 | 0.110 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4758 | 0.110 |
Why?
|
Protein Array Analysis | 1 | 2015 | 400 | 0.110 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2015 | 227 | 0.110 |
Why?
|
Aptamers, Nucleotide | 1 | 2014 | 165 | 0.100 |
Why?
|
Pyrazoles | 1 | 2022 | 2009 | 0.090 |
Why?
|
California | 1 | 2015 | 1430 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1914 | 0.090 |
Why?
|
Ultrasonography, Doppler | 1 | 2012 | 462 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4580 | 0.090 |
Why?
|
Necrosis | 1 | 2014 | 1611 | 0.080 |
Why?
|
Pyrimidines | 1 | 2022 | 3028 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2017 | 0.080 |
Why?
|
Brain | 2 | 2020 | 27120 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2014 | 1251 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1443 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2416 | 0.070 |
Why?
|
Humans | 14 | 2022 | 761572 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2244 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2084 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2580 | 0.050 |
Why?
|
Infant | 3 | 2018 | 36192 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5799 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2022 | 903 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10194 | 0.040 |
Why?
|
Granuloma | 1 | 2022 | 328 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2012 | 2155 | 0.040 |
Why?
|
Neutrophils | 1 | 2012 | 3767 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9610 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 88324 | 0.040 |
Why?
|
Otitis | 1 | 2017 | 21 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.040 |
Why?
|
Child | 4 | 2018 | 80156 | 0.040 |
Why?
|
Adult | 4 | 2022 | 221203 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2017 | 289 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2571 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 17352 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2020 | 1303 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2015 | 1060 | 0.030 |
Why?
|
Animals | 5 | 2022 | 168467 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1762 | 0.030 |
Why?
|
Male | 4 | 2022 | 360842 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.030 |
Why?
|
Headache | 1 | 2020 | 1256 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 814 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2015 | 589 | 0.020 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2012 | 153 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2012 | 363 | 0.020 |
Why?
|
CHO Cells | 1 | 2014 | 1387 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3332 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39107 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1410 | 0.020 |
Why?
|
Anti-Retroviral Agents | 1 | 2020 | 1784 | 0.020 |
Why?
|
Cricetinae | 1 | 2014 | 2423 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2017 | 1359 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15633 | 0.020 |
Why?
|
Virus Diseases | 1 | 2015 | 718 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 2012 | 574 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20571 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1646 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1560 | 0.020 |
Why?
|
Sinusitis | 1 | 2017 | 991 | 0.020 |
Why?
|
Female | 5 | 2020 | 392686 | 0.020 |
Why?
|
Epigenomics | 1 | 2012 | 943 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2014 | 3162 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5428 | 0.020 |
Why?
|
Pneumonia | 1 | 2017 | 2143 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12975 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1974 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10002 | 0.010 |
Why?
|
Child, Preschool | 2 | 2017 | 42230 | 0.010 |
Why?
|
HIV-1 | 1 | 2020 | 6863 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6214 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2747 | 0.010 |
Why?
|
Mice | 3 | 2015 | 81533 | 0.010 |
Why?
|
Aged | 1 | 2014 | 169310 | 0.010 |
Why?
|
Chromatin | 1 | 2012 | 2961 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15732 | 0.010 |
Why?
|
Young Adult | 2 | 2017 | 59255 | 0.010 |
Why?
|
Proteomics | 1 | 2012 | 3848 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15601 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18253 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 18965 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9489 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22172 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41493 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36429 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 30054 | 0.010 |
Why?
|
Middle Aged | 1 | 2020 | 220920 | 0.000 |
Why?
|